Stock Information
Parabilis Medicines Inc (PBLS)
Ticker Symbol: PBLS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,437.83 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -2.04
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: N/A%
Latest News
-
Parabilis Medicines (PBLS) Stock May Trade At A Premium Despite Fresh Zolucatetide Trial Updates
Tue, Oct 20, 2026 8:06 PM
-
Parabilis Medicines (PBLS) Could Be 39% Undervalued As Zolucatetide Trial Expands
Tue, Oct 20, 2026 7:12 PM
-
What Does Parabilis Medicines (PBLS) Expanding Zolucatetide Into FAP Mean?
Tue, Oct 20, 2026 6:17 PM
-
Parabilis: $1B+ Rare-Disease Foundation Leaves The Big Oncology Pipeline For Free
Tue, Oct 20, 2026 1:14 PM
-
Parabilis Soars 13% on Upcoming ESMO Data for “First-in-Class” Desmoid Tumor Drug
Mon, Oct 19, 2026 5:30 PM
-
Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026
Mon, Oct 19, 2026 11:00 AM
-
Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday
Mon, Oct 19, 2026 10:05 AM
-
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
Wed, Oct 14, 2026 11:00 AM
-
Parabilis Medicines Initiates Dose-Ranging Clinical Cohort Evaluating Zolucatetide In Patients With Familial Adenomatous Polyposis As Part Of Ongoing Phase 1/2 Clinical Trial
Wed, Oct 14, 2026 7:05 AM
Key Financials
Financial data not available
